Research Group: Immune Monitoring

Since 2022, scientists at the LIT, led by Prof. Philipp Beckhove, Scientific Director and Head of Interventional Immunology Division, have been investigating intratumoral heterogeneity – the phenomenon that tumors undergo significant individual changes as the disease progresses – as part of the SATURN3 consortium. The Federal Ministry of Research, Technology and Space has extended this funding until June 2027 and increased it by around €220,000 to a total of nearly €600,000.